<table id="_RefID9398F836C70241CBA1A249554CE3B390" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 3. Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin </caption>
<col width="55%"></col>
<col width="23%"></col>
<col width="18%"></col>
<col width="19%"></col>
<thead>
<tr>
<th stylecode="Botrule Lrule Toprule ">
<content stylecode="bold">Co-administered drug and dosing regimen</content>
</th>
<th colspan="3" stylecode="Rrule Botrule Lrule Toprule ">
<content stylecode="bold">Atorvastatin</content>
</th>
</tr>
<tr>
<th stylecode="Lrule Botrule "></th>
<th stylecode="Lrule Botrule ">
<content stylecode="bold">Dose (mg)</content>
</th>
<th stylecode="Lrule Botrule ">
<content stylecode="bold">Change in AUC</content>
<footnote id="_Ref384803164">Data given as x-fold change represent a simple ratio between co-administration and atorvastatin alone (i.e., 1-fold = no change). Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change).</footnote>
</th>
<th stylecode="Rrule Lrule Botrule ">
<content stylecode="bold">Change in Cmax</content>
<footnoteref idref="_Ref384803164"></footnoteref>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>
<footnote id="_Ref384803242">See Sections 5.1 and 7 for clinical significance.</footnote>Cyclosporine 5.2 mg/kg/day, stable dose </paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>10 mg QD for 28 days</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>↑ 8.7 fold</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>↑10.7 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>10 mg, SD</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 9.4 fold</paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 8.6 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Telaprevir 750 mg q8h, 10 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>20 mg, SD</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 7.88 fold</paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 10.6 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>
<sup>, </sup>
<footnote id="_Ref384803337">The dose of saquinavir plus ritonavir in this study is not the clinically used dose. The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study. Therefore, caution should be applied and the lowest dose necessary should be used.</footnote>Saquinavir 400 mg BID/ ritonavir 400mg BID, 15 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>40 mg QD for 4 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 3.9 fold</paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 4.3 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Clarithromycin 500 mg BID, 9 days</paragraph>
</td>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>80 mg QD for 8 days</paragraph>
</td>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>↑ 4.4 fold</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 5.4 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 3.4 fold</paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 2.25 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Itraconazole 200 mg QD, 4 days </paragraph>
</td>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>↑ 3.3 fold</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 20% </paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 2.53 fold </paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 2.84 fold </paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Fosamprenavir 1400 mg BID, 14 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>10 mg QD for 4 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 2.3 fold </paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 4.04 fold </paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Nelfinavir 1250 mg BID, 14 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>10 mg QD for 28 days</paragraph>
</td>
<td stylecode="Lrule " valign="top">
<paragraph>↑ 74% </paragraph>
</td>
<td stylecode="Rrule Lrule " valign="top">
<paragraph>↑ 2.2 fold </paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Grapefruit Juice, 240 mL QD<footnote id="_Ref384803465">Greater increases in AUC (up to 2.5 fold) and/or C<sub>max</sub> (up to 71%) have been reported with excessive grapefruit consumption (≥ 750 mL to 1.2 liters per day). </footnote>
</paragraph>
</td>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>40 mg, SD</paragraph>
</td>
<td stylecode="Lrule Botrule " valign="top">
<paragraph>↑ 37%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 16%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Diltiazem 240 mg QD, 28 days </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>40 mg, SD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 51%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>No change</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Erythromycin 500 mg QID, 7 days </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>10 mg, SD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 33%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 38%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Amlodipine 10 mg, single dose </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>80 mg, SD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 15%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 12 %</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Cimetidine 300 mg QD, 4 weeks </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>10 mg QD for 2 weeks</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ Less than 1%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 11%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Colestipol 10 mg BID, 28 weeks </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>40 mg QD for 28 weeks</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Not determined</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 26%<footnote id="_Ref384803528">Single sample taken 8 to 16 h post dose.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Maalox TC® 30 mL QD, 17 days </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>10 mg QD for 15 days</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 33%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 34%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Efavirenz 600 mg QD, 14 days </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>10 mg for 3 days</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 41%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 1%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Rifampin 600 mg QD, 7 days (co-administered)<footnote id="_Ref384803483">Due to the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations.</footnote>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 30%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 2.7 fold</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Rifampin 600 mg QD, 5 days (doses separated)<footnoteref idref="_Ref384803483"></footnoteref>
</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>40 mg SD</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 80%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ 40%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Gemfibrozil 600mg BID, 7 days </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>40mg SD </paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↑ 35%</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>↓ Less than 1%</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>
<footnoteref idref="_Ref384803242"></footnoteref>Fenofibrate 160mg QD, 7 days</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>40mg SD </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>↑ 3%</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>↑ 2%</paragraph>
</td>
</tr>
</tbody>
</table>